IL17A and metabolic dysfunction-associated steatotic liver disease: KEGG enrichment analysis of the 98 targets revealed that the treatment of NAFLD is primarily associated with the AGE-RAGE signaling pathway in diabetic complications, HIF-1 signaling pathway, and IL-17 signaling pathway.